• 1. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 2. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782

Chemical Profile of 1H-Pyrrolo[2,3-b]pyridine-5-carbonitrile,4-chloro-1-[tris(1-methylethyl)silyl] (CAS No. 920966-01-4)

The compound 1H-Pyrrolo[2,3-b]pyridine-5-carbonitrile,4-chloro-1-[tris(1-methylethyl)silyl] (CAS No. 920966-01-4) represents a significant advancement in the field of heterocyclic chemistry and pharmaceutical research. This intricate molecular structure, featuring a fused pyrrolopyridine core with functionalized substituents, has garnered considerable attention due to its potential applications in medicinal chemistry and drug discovery. The presence of a chloro group at the 4-position and a tris(1-methylethyl)silyl (TMS) protecting group at the 1-position introduces unique reactivity and stability characteristics, making it a valuable intermediate in synthetic organic chemistry.

Recent studies have highlighted the utility of this compound in the development of novel therapeutic agents. The pyrrolopyridine scaffold is a privileged structure in medicinal chemistry, often found in bioactive molecules targeting various biological pathways. Specifically, derivatives of 1H-Pyrrolo[2,3-b]pyridine have shown promise in inhibiting kinases and other enzymes involved in cancer metabolism. The carbonitrile functionality at the 5-position further enhances its pharmacological potential by contributing to hydrogen bonding interactions and influencing electronic properties. This combination of structural features makes it an attractive candidate for further exploration.

The chloro substituent at the 4-position serves multiple purposes in synthetic chemistry. It acts as a versatile handle for further functionalization via nucleophilic aromatic substitution or cross-coupling reactions, enabling the construction of more complex molecular architectures. Additionally, the electron-withdrawing nature of the chloro group can modulate the reactivity of adjacent functional groups, providing fine-tuned control over synthetic pathways. Such modularity is crucial in drug development, where precise structural modifications can significantly impact biological activity.

The tris(1-methylethyl)silyl (TMS) group at the 1-position is another key feature that contributes to the compound's utility. TMS silyl groups are widely employed in organic synthesis due to their stability under various reaction conditions and their ability to protect reactive hydroxyl or carboxylic acid groups. In this context, the TMS group at the 1-position of 1H-Pyrrolo[2,3-b]pyridine-5-carbonitrile,4-chloro-1-[tris(1-methylethyl)silyl] ensures that this position remains unreactive until selectively deprotected when desired. This level of control is essential for multi-step syntheses where regioselectivity is paramount.

Current research trends indicate that this compound is being explored in the development of small-molecule inhibitors targeting protein-protein interactions (PPIs). PPIs are critical mediators of cellular signaling pathways and are implicated in numerous diseases, including cancer and inflammatory disorders. The rigid heterocyclic core of 1H-Pyrrolo[2,3-b]pyridine provides a scaffold for designing molecules that can disrupt these interactions by binding to specific pockets on target proteins. The additional functional groups—such as the carbonitrile, chloro, and TMS—offer opportunities to optimize binding affinity and selectivity through structure-based drug design.

In addition to its pharmaceutical applications, this compound has potential uses in materials science and agrochemical research. The unique electronic properties conferred by its fused ring system make it a candidate for developing organic semiconductors or ligands for catalytic systems. Furthermore, modifications to its structure could yield novel agrochemicals with enhanced efficacy against pests or pathogens while maintaining environmental safety profiles.

The synthesis of 1H-Pyrrolo[2,3-b]pyridine-5-carbonitrile,4-chloro-1-[tris(1-methylethyl)silyl] presents both challenges and opportunities for synthetic chemists. The construction of the pyrrolopyridine core requires careful consideration of reaction conditions to ensure high yield and purity. Advances in transition-metal-catalyzed reactions have made it possible to construct such heterocycles more efficiently than ever before. For instance, palladium-catalyzed cross-coupling reactions can be employed to introduce the chloro and TMS groups with high precision.

Future directions in research may involve exploring derivatives of this compound with altered substituents to improve their pharmacokinetic properties or expand their therapeutic spectrum. Computational modeling techniques are increasingly being used to predict how structural changes will affect biological activity, allowing for rapid screening of potential candidates before experimental synthesis begins. This interdisciplinary approach combines expertise from organic chemistry, medicinal chemistry, and computational science to accelerate drug discovery efforts.

The versatility of CAS No. 920966-01-4 as a building block underscores its importance in modern chemical research. Its ability to serve as a precursor for multiple classes of bioactive molecules makes it a cornerstone in libraries designed for high-throughput screening (HTS). HTS campaigns rely on large collections of diverse compounds to identify leads with promising pharmacological activity rapidly—a process where compounds like this one play an indispensable role.

In conclusion,1H-Pyrrolo[2,3-b]pyridine-5-carbonitrile,4-chloro-1-[tris(1-methylethyl)silyl] represents a compelling example of how structural complexity can be leveraged to develop innovative solutions in pharmaceuticals and beyond. Its unique combination of functional groups provides chemists with ample opportunities for creative synthesis while offering researchers a platform for exploring new therapeutic modalities.

• 889942-31-8(Benzenamine,2-[1-(2-phenylethyl)-4-piperidinyl]-)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)